<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346890</article-id>
      <article-id pub-id-type="pmc">3876018</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132398</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Lucio's Phenomenon. Case study of an exceptional response to treatment
exclusively with multibacillary multidrug therapy<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Fen&#xF4;meno de L&#xFA;cio. Relato de um caso exuberante com excelente resposta
ao tratamento com Poliquimioterapia Multibacilar</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Peixoto</surname>
            <given-names>Amanda Braga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Portela</surname>
            <given-names>Poliana Santin</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leal</surname>
            <given-names>Fabiano Roberto Pereira de Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brotas</surname>
            <given-names>Arles Martins</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>Nilton Carlos dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD - Post-graduation in Dermatology at Marc&#xED;lio Dias Naval Hospital
(HNMD) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff02"><label>2</label> Assistant professor at Rio de Janeiro Pontifical Catholic University
(PUC-RJ) and at Professor Rubem David Azulay Institute dermatology clinics &#x2013; Preceptor
at Santa Casa de Miseric&#xF3;rdia do Rio de Janeiro Hospital and at Marc&#xED;lio Dias Naval
Hospital (HNMD) &#x2013; Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, PhD in dermatology at Rio de Janeiro State University (UERJ) -
Preceptor at Marc&#xED;lio Dias Naval Hospital dermatology clinics (HNMD) - Rio de Janeiro
(RJ), Brazil.</aff>
      <aff id="aff04"><label>4</label> Military Commander at Marc&#xED;lio Dias Naval Hospital dermatology clinics
(HNMD) - Rio de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Amanda Braga Peixoto, Rua Cesar Zama, 185 - Lins de
Vasconcelos, 20725-090 - Rio de Janeiro - RJ Brazil. E-mail:
<email>amandabrag@globo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>93</fpage>
      <lpage>96</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>3</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Lucio's phenomenon represents a serious cutaneous necrotizing reaction, which can
occur with Lucio's leprosy and also in other forms of lepromatous leprosy. The
authors discuss the case of a 63-year-old male patient presenting with ulcers and
necrotic cutaneous lesions on the limbs, torso and face, associated with recurring
sinusitis, hoarseness and a weight loss of 25 kilos over the last year. Bacilloscopy
of intradermal scrapings showed a bacilloscopic index of 5 and the histopathological
findings were compatible with the diagnosis of Lucio's phenomenon. The chosen
treatment was exclusively multibacillary multidrug therapy, resulting in important
dermatological improvement after one month of therapy. The authors present an
impressive case of Lucio's phenomenon with an exceptional response to treatment
exclusively with multibacillary multidrug therapy.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>O fen&#xF4;meno de L&#xFA;cio representa uma rea&#xE7;&#xE3;o cut&#xE2;nea necrosante grave que pode ocorrer
na hansen&#xED;ase de L&#xFA;cio e em outras formas de hansen&#xED;ase virchowiana. Os autores
relatam o caso de um paciente masculino de 63 anos de idade apresentando h&#xE1; um ano
les&#xF5;es ulceronecr&#xF3;ticas nos membros, l&#xF3;bulos auriculares e tronco, associadas a
sinusite de repeti&#xE7;&#xE3;o, rouquid&#xE3;o e perda ponderal de 25 kg. A baciloscopia de raspado
intrad&#xE9;rmico mostrou &#xED;ndice bacilosc&#xF3;pico de 5 e o exame histopatologico foi
compat&#xED;vel com fen&#xF4;meno de L&#xFA;cio. O tratamento institu&#xED;do foi exclusivamente com
poliquimioterapia multibacilar (PQT-MB), havendo melhora importante do quadro cut&#xE2;neo
ap&#xF3;s um m&#xEA;s de tratamento. Os autores apresentam um caso exuberante de fen&#xF4;meno de
L&#xFA;cio que obteve excelente resposta ao tratamento somente com PQT-MB.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Drug therapy, combination</kwd>
        <kwd>Leprosy, lepromatous</kwd>
        <kwd>Treatment outcome</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Hansen's disease or leprosy is a chronic infec-trum of leprosy is linked to variations
on the patient's tious illness that is considered endemic in Brazil. It is immune
responses to the infection. Therefore, leprocaused by the Mycobacterium leprae (M
leprae), matous leprosy occurs in subjects that present with a which is transmitted via
respiratory route, after a deficiency in the cellular immunity response to M leplengthy
and intimate contact with an untreated bacil-rae, while tuberculoid leprosy is linked to
a higher liferous patient.<sup><xref ref-type="bibr" rid="r01">1</xref></sup> Depending
on the patient's immune resistance to the bacillus. Intermediate leprosy presensystem,
the infection may evolve to cure or to one of tations, including borderline tuberculoid,
borderline-its clinical presentations: indeterminate, tuberculoid, borderline and
borderline lepromatous are unstable borderline or lepromatous.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> The wide clinical spec-forms of the disease. Leprous
reactions are acute and frequent manifestations that disrupt the indolent chronic course
of the disease and reflect the immunological instability of the patient. According to
the clinical and histopathological manifestations, reaction cases may be classified as:
type 1 or reversal reaction, and type 2 including erythema nodosum leprosum, erythema
polymorphe and Lucio's phenomenon. Some authors recognize the latter condition as a
reaction type 3. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A sixty-three year old male patient informed the gradual appearance of painless
hemorrhagic blisters on limbs, earlobes and torso one year ago. These lesions later
regressed spontaneously, leaving only atrophic scars on their previous sites. He also
reported several bouts of recurring sinusitis, hoarseness and progressive worsening of
the cutaneous lesions. This patient had a previous history of Chronic Obstructive
Pulmonary Disease (COPD), hyperuricemia and high blood pressure treated with an
irregular use of nifedipine. He denied smoking, drinking or the use of illicit drugs and
he also had no family history of dermatologic diseases similar to his own. During
admission, the patient status was cachectic; he was dehydrated, asthenic, dyspneic and
afebrile (<xref ref-type="fig" rid="f01">Figure 1</xref>). Physical examination showed
an infiltrated face, with madarosis, besides ulceronecrotic geometrically shaped lesions
affecting the limbs, torso and face. In some segments, these lesions would converge;
leaving large denuded areas (<xref ref-type="fig" rid="f02">Figure 2</xref>). Neurologic
examination demonstrated bilaterally thickened fibular nerves, which were painless to
palpation. Laboratory exams revealed anemia (hemoglobin: 9.5 g/dL; hematocrit: 29.9%;
MVC: 76.5 fL), bandemia (10%), hypoproteinemia (5.1g/dL), and elevated levels of C
reactive protein (CRP) and erythrocyte sedimentation rate (ESR) (27.4 mg/L and 82 mm/h
respectively); Anti-HIV, VDRL, Antinuclear Factor (ANF), Anti-DNA e anti-cardiolipin
antibodies (ACA) were all negative. Skin smear bacilloscopy demonstrated a bacilloscopic
level of 5 (i.e. the presence of an average of 100 to 1,000 bacilli per examined field).
The results of a biopsy on a forearm opened lesion showed an ulcerated epidermis,
accompanied by a dense histiocitary infiltrate with peri-adnexal and interstitial
distribution; the presence of vascular fibrinoid necrosis with neutrophilic infiltrate
and associated edema; also the presence of numerous granular bacilli by the Fite-Faraco
stain, often arranged in a cluster-like formation (<xref ref-type="fig" rid="f03">Figure
3</xref>). The histopathological findings were compatible with the diagnosis of
Virchowian hanseniasis, exhibiting Lucio's phenomenon reaction. Radiographies of the
hands showed bone resorption on the right fifth digit; rhinoscopy visualized a nasal
septal perforation; a decrease of diameter in the glottic region was detected by the
videolaringoscopy; and the Mitsuda test was negative. The treatment of choice was
exclusively with multibacillary multidrug therapy leading to a marked improvement in the
cutaneous signs and symptoms after one month of use (<xref ref-type="fig" rid="f04">Figure 4</xref>). </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Crusted ulcerated lesions mainly in the oral and nasal cavities and presence of
madarosis</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0093-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Converging of lesions, leaving large denuded areas</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0093-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Presence of innumerous granular bacilli by the Fite-Faraco stain</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0093-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Impressive recovery after one month of treatment</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0093-g04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Lucio's phenomenon (FL) represents a severe cutaneous necrosis reaction that may occur
in Lucio's leprosy and also in other forms of Virchowian hanseniasis.<sup><xref ref-type="bibr" rid="r02">2</xref></sup> This is a rare syndrome, almost
exclusively limited to patients with leprosy from Mexico and Central America, although
it is rarely reported in Cuba, South America, United States, India, Polynesia, South
Africa and Southeast Asia. FL occurs 3 to 4 years into the course of the disease and it
is most common in patients that are either untreated or inadequately treated.<sup><xref ref-type="bibr" rid="r03">3</xref></sup> This reaction is characterized by bouts
of slightly infiltrated erythematous macules, which evolve with central necrosis and
subsequent ulceration. These lesions affect mainly the extremities and usually regress
in a period of two to four weeks, leaving atrophic star-like scars.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup>
The presence of dark, flaccid blisters may be observed.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> Many Virchowian hanseniasis' characteristics are often
described, such as: thickening of the facial skin, alopecia in the eyebrows and
eyelashes, paresthesia on the extremities and rhinitis.<sup><xref ref-type="bibr" rid="r07">7</xref></sup> FL's pathophysiology is still unknown, however, it is a
consensus that this is a thrombo-occlusive process. The main hypothesis is that
bacterial liposaccharides would stimulate macrophages to release TNF and interleukin1
(IL-1). Those products would act on the endothelial cells facilitating the production of
prostaglandins, interleukin-6 (IL-6) and coagulation factor III, thus causing the
formation of thrombi inside the vessels and also promoting tissue necrosis on
predisposed patients.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> Histologic
examination demonstrates: a decrease in the vascular lumen due to endothelial cellular
proliferation; capillary thrombosis on the superior and medium dermis resulting in an
ulcerated epidermis; inflammatory infiltrate with foamy histiocytes and innumerous
bacilli, even inside the vascular walls.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> There are few reports of leukocytoclastic vasculitis in early
lesions. All these findings may be observed both in the clinically altered skin as well
as in the apparently healthy one. Among several differential diagnosis, one must
consider the erythema nodosum leprosum (a neutrophilic vasculitis, mediated by
immunocomplexes, with variable involvement of the panniculus), easily distinguished by
the presence of painful nodules that rarely ulcerate, small quantity of bacilli and
general symptoms like fever, adenomegaly, apathy, possibly arthrites, neurites,
iridocyclites and the fact that it affects more frequently those patients on the first
six months of treatment. Multibacillary multidrug therapy (PQT-MB) is the treatment of
choice for FL. What supports this theory is the massive replication of M leprae, a
triggering event for FL that must be arrested in order to stop the leprosy reaction. The
role of corticosteroids is still controversial. In the clinical case described above, we
did not include corticoids due to the risk of severe infection. The progressive
improvement of the patient, in a matter of few days, ratified our choice. Thalidomide
and clofazimine are less effective to treat erythema nodosum leprosum (ENL). Prognosis
is variable, and may result in death by sepsis or coagulation disorders.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> The authors discussed the case of a
patient with exuberant FL manifestations, which presented an excellent response to
treatment with only PQT-MB.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at Marc&#xED;lio Dias Naval Hospital (HNMD) - Rio de Janeiro (RJ),
Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Sa&#xFA;de.gov.br [p&#xE1;gina da internet]</collab>
            <collab>Brasil</collab>
            <collab>Minist&#xE9;rio da sa&#xFA;de</collab>
            <collab>Secretaria de Pol&#xED;ticas de Sa&#xFA;de</collab>
            <collab>Departamento de Aten&#xE7;&#xE3;o B&#xE1;sica</collab>
          </person-group>
          <source xml:lang="pt">Guia para o controle da Hansen&#xED;ase</source>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Minist&#xE9;rio da Sa&#xFA;de</publisher-name>
          <year>2002</year>
          <date-in-citation content-type="access-date">acesso 26 jul 2012</date-in-citation>
          <comment>Dispon&#xED;vel em: <ext-link ext-link-type="uri" xlink:href="http://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf">http://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf</ext-link>
Guideline for the control of Hanseniasis. Available in Portuguese at <ext-link ext-link-type="uri" xlink:href="http://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf">http://bvsms.saude.gov.br/bvs/publicacoes/guia_de_hanseniase.pdf</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helmer</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>kucharski-Fleischfresser</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Esmanhoto</surname>
              <given-names>LDK</given-names>
            </name>
          </person-group>
          <article-title>The Lucio's phenomenon (necrotizing erythema) in
pregnancy</article-title>
          <source>An Bras Dermatol</source>
          <year>2004</year>
          <volume>79</volume>
          <fpage>205</fpage>
          <lpage>210</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Thappa</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Basu</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A fatal case of Lucio's phenomenon from India</article-title>
          <source>Dermatol Online J</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>10</fpage>
          <pub-id pub-id-type="pmid">18700113</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Lucio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Alvarado</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <source xml:lang="es">Opusculo Sobre el Mal de San Lazaro O, Elefan ciasis de los
Griegos</source>
          <publisher-loc>Mexico</publisher-loc>
          <publisher-name>M. Murguia y Cia</publisher-name>
          <year>1852</year>
          <fpage>53</fpage>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latapi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zamora</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>The "spotted" leprosy of Lucio (la lepra manchada de Lucio): An
introduction to its clinical and histological study</article-title>
          <source>Int J Lepr</source>
          <year>1948</year>
          <volume>16</volume>
          <fpage>421</fpage>
          <lpage>430</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azulay-Abulafia</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Spinelli</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Revendo a Hansen&#xED;ase de Lucio e o Fen&#xF4;meno de Lucio
(Revisiting Lucio's leprosy and Lucio's phenomenon)</article-title>
          <source>Med Cutan Lat Am</source>
          <year>2004</year>
          <volume>33</volume>
          <fpage>125</fpage>
          <lpage>133</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>NSC.gov.sg [homepage on the Internet]</collab>
            <name>
              <surname>Por</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kwang</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Swee</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Lucio's Phenomenon: A rare necrotizing Type 2 reaction in lepromatous
leprosy</article-title>
          <source>Bulletin for medical practitioners</source>
          <publisher-name>National Skin Centre Singapore</publisher-name>
          <year>1995</year>
          <date-in-citation content-type="access-date">cited 2012 Jul 26</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nsc.gov.sg/showpage.asp?id=328">http://www.nsc.gov.sg/showpage.asp?id=328</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vargas-Ocampo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Diffuse leprosy of Lucio and Latap&#xED;: a histologic
study</article-title>
          <source>Lepr Rev</source>
          <year>2007</year>
          <volume>78</volume>
          <fpage>248</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">18035776</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
